Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine.
MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T.
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity.
The value of specialty pharmaceuticals - a systematic review.
Identifying autoantigens in demyelinating diseases: valuable clues to diagnosis and treatment?
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Complementary and alternative medicine in multiple sclerosis.
Natural History of Multiple Sclerosis Symptoms
Animal Models in Neurology: Drawbacks and Opportunities.
Receptos provides update on progress of lead product candidate RPC1063
Memory rehabilitation for people with multiple sclerosis.
Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis.
Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
Detecting cortical lesions in multiple sclerosis at 7 T using white matter signal attenuation.
Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
Multiple sclerosis: Risk of comorbid inflammatory diseases in MS might not be genetically determined.
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.
Normal outcome of pregnancy with ongoing treatment with natalizumab.
High dose naltrexone for dyskinesias induced by levodopa.
Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid.
Potential T cell epitopes of Mycobacterium tuberculosis that can instigate molecular mimicry against host: implications in autoimmune pathogenesis.
Fingolimod Therapy in Early Multiple Sclerosis: An Efficacy Analysis of the TRANSFORMS and FREEDOMS Studies by Time Since First Symptom.
Tysabri
Atypical guillain-barré syndrome misdiagnosed as lumbar spinal stenosis.
Pages
« first
‹ previous
…
107
108
109
110
111
112
113
114
115
…
next ›
last »